Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 3Neoplasms 3Gastrointestinal Neoplasms 2Depression 2Anxiety Disorders 2Peripheral Nervous System Diseases 1Pain, Postoperative 1Otolaryngeal Cancer 1Neurotoxicity Syndromes 1Mucositis 1Lung Neoplasms 1Head and Neck Neoplasms 1Cancer Pain 1Breast Neoplasms 1Agnosia 1Acute Pain 1

Interventions

Glutamine 3Physical Therapy Modalities 2Acupuncture Therapy 2glutamic acid diethyl ester 1Thioctic Acid 1Sugars 1Pain Management 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Minocycline 1Low-Level Light Therapy 1Ketamine 1Glutamic Acid 1Exercise 1Epoetin Alfa 1Duloxetine Hydrochloride 1Dietary Supplements 1Biopsy 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Peripheral Nervous System Diseases × Ketamine × Clear all
NCT00471445 2015-11-09

Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients

University of Rochester

Phase 3 Completed
462 enrolled 14 charts

Pain, Peripheral Nervous System Diseases, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡